Clinical Trial: A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

Sponsor and Collaborators
University of Pittsburgh
National Cancer Institute (NCI)

Contact
Athanassios Argiris, MD
(412) 623-4083
[email protected]

Rita Johnson, RN
(412) 547-5871
[email protected]

United States, Michigan
University of Michigan Recruiting
Ann Arbor, Michigan, United States, 48109-0848
Principal Investigator: Francis P Worden, MD

United States, Ohio
Case Western Reserve University Recruiting
Cleveland, Ohio, United States, 44106
Principal Investigator: Panayiotis Savvides, MD, PhD, MPH

United States, Pennsylvania
UPMC / UPMC Cancer Centers Recruiting
Pittsburgh, Pennsylvania, United States, 15232
Contact: Jamie Haggerty
Principal Investigator: Athanassios Argiris, MD

United States, Texas
University of Texas MD Anderson Recruiting
Houston, Texas, United States, 77030
Principal Investigator: Merrill s Kies, MD

Principal Investigator
Athanassios Argiris, MD
ECOG

Clinical Trials.gov Identifier
NCT00409565